NIAGARA investigator Thomas Powles at #ESMO24 (Reynald Castaneda for Endpoints News)

September 16, 2024 03:59 AM EDTUpdated 06:24 AM

AstraZeneca unveils what it calls ‘practice-changing’ Imfinzi data in bladder cancer

Reynald Castañeda

Deputy Editor

BARCELONA — In a result that’s likely to change how some bladder cancer patients get care, AstraZeneca said that its drug Imfinzi boosted patient survival alongside …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

AstraZeneca unveils what it calls ‘practice-changing’ Imfinzi data in bladder cancer

Reynald Castañeda

Deputy Editor

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Here's what today's Fed rate cut means for biotech, pharma and venture capital

FDA cancels Applied Therapeutics adcomm, shares skyrocket 65%

All of 23andMe's independent board members resign over disagreements with CEO

Conducting trials via routine clinical practice: FDA explains how in new draft guidance

You bet your life: After I was diagnosed with a rare cancer, I discovered how a small band of physician-scientists ...

Breaking down silos with a new quantitative approach to drug development

As­traZeneca un­veils what it calls ‘prac­tice-chang­ing’ Imfinzi da­ta in blad­der can­cer

Deputy Editor

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

AstraZeneca unveils what it calls ‘practice-changing’ Imfinzi data in bladder cancer